3783 results for «2026»

Filter By

3783 results

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

20 May 2026 – From EuroPCR 2026

This session examines the clinical evidence and experiential insights regarding the MagicTouch sirolimus-coated balloon (SCB) for treating coronary and peripheral artery disease. It reviews long-term comparative data versus paclitaxel-coated balloons, application techniques, integration into current practices, and findings from major trials such as SIRONA and SIMPLE-DM,...

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

Angiography-based physiology: time to change your routine clinical practice?

20 May 2026 – From EuroPCR 2026

This session offers a critical appraisal of angiography-based physiology, with a focus on virtual fractional flow reserve (vFFR) technology. It reviews the latest clinical evidence, including insights from the FAST study programme and the FAST III randomised controlled trial. Gain a clear understanding of current guideline...

Angiography-based physiology: time to change your routine clinical practice?

Beyond visualisation: the value and future of 4D intracardiac echocardiography in tricuspid repair and replacement

20 May 2026 – From EuroPCR 2026

Explore the transformative role of 4D intracardiac echocardiography in guiding tricuspid edge-to-edge repair (TEER) and valve replacement for tricuspid regurgitation. This session highlights how real-time, high-resolution imaging enhances procedural efficiency and safety, reducing reliance on general anesthesia and shortening procedure times compared to traditional imaging modalities.

Beyond visualisation:

Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection

20 May 2026 – From EuroPCR 2026

This session elucidates the role of non-invasive coronary CT and angiography-derived physiology in guiding lesion selection for drug-eluting balloon PCI. It emphasises integrating anatomical and physiological data to refine lesion preparation, strategy, and validation beyond angiography, and identifies scenarios where DEB PCI may not be optimal,...

Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection

Reshaping what's possible in complex PCI with advanced sirolimus technology

21 May 2026 – From EuroPCR 2026

Focused on advancing complex PCI, this session explores strategies to minimise metal use through advanced sirolimus technologies and drug-coated balloon (DCB) therapies. It highlights the biological and pharmacokinetic characteristics of DCBs, key device design considerations, and practical approaches to less-metal PCI. Clinical cases illustrate challenges such...

Reshaping what's possible in complex PCI with advanced sirolimus technology

From 3D coronary imaging to calcium modification, the future of PCI starts now

21 May 2026 – From EuroPCR 2026

This session delves into the cutting-edge integration of 3D coronary imaging and calcium modification techniques in percutaneous coronary intervention (PCI). Participants will understand how 3DStent visualization enhances PCI optimization beyond conventional angiography, learn to characterize coronary calcification pre-PCI using advanced imaging tools, and incorporate practical workflows...

From 3D coronary imaging to calcium modification, the future of PCI starts now

Beyond the horizon - A prelude into TAVI and complex PCI solutions

19 May 2026 – From EuroPCR 2026

This session provides a comprehensive preview of evolving technologies and strategies shaping interventional cardiology. Discover the Myval Octapro+ transcatheter heart valve (THV) and its innovative design and procedural benefits demonstrated through a recorded case. Stay updated on Landmark and Compare TAVI trial data, and discover the...

Beyond the horizon - A prelude into TAVI and complex PCI solutions

TAVI and coronary artery disease: we need the COMPLETE answer!

19 May 2026 – From EuroPCR 2026

Addressing the intersection of transcatheter aortic valve implantation (TAVI) and coronary artery disease, this session reviews contemporary surgical and interventional literature to elucidate current practices. It underscores the need for a large international randomized controlled trial to provide definitive guidance for managing patients with concomitant aortic...

TAVI and coronary artery disease: we need the COMPLETE answer!

Large-bore venous access and vessel closure: all you need to know

19 May 2026 – From EuroPCR 2026

This session provides a comprehensive guide to large-bore venous access and vessel closure techniques, emphasizing best practices and the advantages of ultrasound-guided suture mediated vessel closure compared to traditional figure-of-eight suture methods. It also addresses strategies to avoid and manage potential complications encountered during these procedures.

Large-bore venous access and vessel closure: all you need to know

Align for the future with structural heart innovations - LIVE case and major trial updates

19 May 2026 – From EuroPCR 2026

Stay abreast of structural heart innovations with expert discussions on best-in-class transcatheter aortic valve implantation (TAVI) practices, including imaging, sizing, and procedural strategies. This session with LIVE case introduces the novel Myval Octapro+ transcatheter heart valve (THV), its design philosophy, and potential clinical benefits, along with...

Align for the future with structural heart innovations - Live case and major trial updates

Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes

20 May 2026 – From EuroPCR 2026

This session explores how to optimise left main PCI through the integration of intracoronary imaging and physiology using Ultreon 3.0 software. It highlights how this innovative technology supports decision-making, procedural planning, and stent optimisation to improve outcomes in complex lesion management.

Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes

Beyond the horizon - Future of structural heart innovations and PCI

20 May 2026 – From EuroPCR 2026

Structural heart and coronary interventions are expanding rapidly, with innovation increasingly focused on managing complex anatomies and diversifying treatment strategies.

The PRISM-PCI toolkit is introduced as a framework to support decision-making in complex PCI, alongside advances in transcatheter valve therapies spanning mitral, tricuspid and pulmonary interventions, as...

Beyond the horizon - Future of structural heart innovations and PCI

Seeing differently, treating better: advanced imaging shaping modern structural heart practice

20 May 2026 – From EuroPCR 2026

This session explores the transformative role of advanced imaging, particularly 3D intracardiac echocardiography (ICE), in modern structural heart interventions. It provides practical insights into implementation, highlighting how these tools can enhance workflow efficiency and procedural confidence across transcatheter edge-to-edge repair (TEER), left atrial appendage (LAA) closure,...

Seeing differently, treating better: advanced imaging shaping modern structural heart practice

PRISM-PCI - From clarity to cure

20 May 2026 – From EuroPCR 2026

PRISM-PCI offers cutting-edge imaging innovations and treatment strategies aimed at optimizing complex PCI procedures. This session explores the 'leave nothing behind' concept with thin-strut bioresorbable scaffolds and sirolimus drug-coated balloons, updates on ultra thin-strut DES platforms, including the SORT OUT XII trial, and introduces a comprehensive...

PRISM-PCI - From clarity to cure

The continuum of valvular heart disease: a lifetime management approach

21 May 2026 – From EuroPCR 2026

This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...

The continuum of valvular heart disease: a lifetime management approach

Navigating high-thrombus burden in ACS: precision aspiration thrombectomy with CAT RX

21 May 2026 – From EuroPCR 2026

This session explores the challenges of managing high thrombus burden in patients with acute coronary syndromes (ACS), with a focus on precision aspiration thrombectomy using the CAT RX device. Through case-based examples, it provides practical insights into procedural techniques and examines the role of CAT RX...

Navigating high-thrombus burden in ACS: precision aspiration thrombectomy with CAT RX

IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension

20 May 2026 – From EuroPCR 2026

This session introduces the IBERIS system, the first radial-access platform for renal denervation in patients with uncontrolled hypertension. It covers patient selection, procedural planning, and key technical considerations for both transfemoral and transradial approaches. A LIVE case demonstration highlights essential procedural steps while addressing the clinical...

IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension

Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?

20 May 2026 – From EuroPCR 2026

Examine the clinical relevance of TAVI valve durability and its impact on long-term patient management in aortic stenosis. Review key factors influencing valve performance over time, with a focus on procedural and anatomical determinants of optimal outcomes.

Current concepts and techniques aimed at achieving ideal valve expansion...

Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?

Real world practice inspiring new evidence generation in structural heart

21 May 2026 – From EuroPCR 2026

This LIVE case session showcases real-world clinical practice driving new evidence in structural heart interventions, with a focus on TAVI. It features expert insights into pre-procedural imaging and sizing, treatment strategies, procedural techniques, and post-procedural management. The session also introduces the novel Myval Octapro+ transcatheter heart...

Real world practice inspiring new evidence generation in structural heart

TAVI vs. surgery - Are the latest long-term data creating a dilemma for aortic stenosis patients?

21 May 2026 – From EuroPCR 2026

This session critically evaluates the latest long-term data comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). It explores differing perspectives between surgeons and interventional cardiologists regarding valve durability and lifetime management, fostering a high-quality debate to achieve consensus within Heart Team discussions...

TAVI vs. surgery - Are the latest long-term data creating a dilemma for aortic stenosis patients?
Didn’t find what you were looking for?